Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review-Reference-Cited by-同舟云学术

Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review

Published:2020-09 Issue: Volume:153 Page:103029
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Assi Tarek^ORCID,Kattan Joseph,Rassy Elie,Nassereddine Hussein,Farhat Fadi,Honore Charles,Le Cesne Axel,Adam Julien,Mir Olivier^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference50 articles.

1. Frequent amplification of receptor tyrosine kinase genes in well-differentiated/dedifferentiated liposarcoma;Asano;Oncotarget,2017

2. A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma;Assi;Cancer Treat. Rev.,2019

3. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data;Binh;Am. J. Surg. Pathol.,2005

4. Improved survival using specialized multidisciplinary board in sarcoma patients;Blay;Ann. Oncol.,2017

5. STRASS (EORTC 62092): A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients with Retroperitoneal Sarcoma;Bonvalot,2019

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular tumor board as a step in cancer patient management: a southern Italian experience;Frontiers in Medicine;2024-09-11

2. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases;Modern Pathology;2024-06

3. New targeted therapies in liposarcoma: state of art and future perspectives;Current Opinion in Oncology;2024-05-07

4. An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies;Journal of Molecular Histology;2024-05-02

5. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms;Cancer Treatment Reviews;2024-04